Communiqués Marpai, Inc.

Actions

MRAI

US5713542083

Logiciels

Temps Différé OTC Markets 17:43:28 10/09/2026			Varia. 5j.	Varia. 1 janv.
3,915 ^USD	-4,74%		+49,00%	+520,44%

13/08	Calvin Steven Mitchell engage des discussions avec Marpai, Inc	CI
13/08	Marpai, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Communiqués

13/08	Marpai Reports Second Quarter 2026 Financial Results	PR
29/07	Marpai Announces $12 Million Private Placement led by Mitchell Companies	PR
20/07	Marpai Inc. Announces Debt Restructuring Agreements with JGB Capital and AXA, Reducing Debt Service by $26.4 Million Through 2027 and Enhances Near term Liquidity	PR
26/05	Marpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026	PR
11/05	Marpai, Inc. Announces Significant New Business Wins across TPA and MarpaiRx; Solidifies Forecast for Profitability	PR
01/04	Marpai, Inc. Secures Major Strategic Marketing Collaboration to Continue Acceleration of MarpaiRx Growth Nationwide	PR
09/03	Marpai Secures Access to Network Creating Major Growth Catalyst for MarpaiRx Representing Up to 1.5 million Covered Lives	PR
23/02	Marpai, Inc. Secures Major Strategic Wins for MarpaiRx, Adding Over 19,000 Lives and Accelerating High-Growth Platform Expansion	PR
27/01	MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH	PR
22/01	MARPAI ANNOUNCES 2026 MOMENTUM and KEY PARTNERSHIP EXPANSION	AQ
01/12	MARPAI ANNOUNCES 2026 MOMENTUM AND KEY PARTNERSHIP EXPANSION	PR
12/11	MARPAI REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS	PR
14/10/25	MARPAI RECOGNIZED AS 2025 TOP THIRD PARTY ADMINISTRATOR	PR
06/10/25	MARPAI, INC. RECEIVES ADDITIONAL $200,000 INVESTMENT FROM DAMIEN LAMENDOLA'S HILLCOUR INVESTMENT FUND	PR
13/08/25	MARPAI REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS	PR
24/07/25	MARPAIRX REVOLUTIONIZES PHARMACY BENEFITS WITH UNPRECEDENTED TRANSPARENCY AND SAVINGS	PR
14/05/25	MARPAI REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS	PR
13/05/25	MARPAI HIRES DALLAS SCRIP AS CHIEF OPERATING OFFICER	PR
26/03/25	MARPAI REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS	PR
18/03/25	MARPAI ACCELERATES HEALTHCARE TRANSFORMATION WITH EMPARA COLLABORATION, LAUNCHING UNIFIED HEALTH ENGAGEMENT PLATFORM	PR
06/01/25	MARPAI ANNOUNCES SECOND TRANCHE OF NON-DILUTIVE GROWTH FUNDING WITH UP TO $5 MILLION FROM JGB	PR
10/12/24	MARPAI : ANNOUNCES PRICING OF $700,000 PRIVATE PLACEMENT Form 8 K	PU
05/12/24	MARPAI ANNOUNCES PRICING OF $700,000 PRIVATE PLACEMENT	PR
26/11/24	MARPAI ANNOUNCES GENERAL UPDATES FOR Q4	PR
12/11/24	MARPAI : reports Third QUARTER 2024 financial results Form 8 K	PU